Marika Charalambous
GROUP LEADER
- King's email
Marika obtained a BA and MA in Natural Sciences from the University of Cambridge. She completed a PhD at the University of Bath on the epigenetic regulation and roles of imprinted genes in fetal growth and placental development.
Her postdoctoral studies included work on metabolic signalling in the insulin-like growth factor (IGF)/insulin axis, then a return to imprinting in the Ferguson-Smith group at the University of Cambridge. Here Marika explored the relationships between epigenetic gene dosage regulation, early life growth and adipose development, and adult metabolic health.
Marika established her own research group at Queen Mary University of London in 2013 as an MRC New Investigator, beginning a programme of study to understand how molecular signals mediate cross-talk between the mother and conceptus during pregnancy. In 2017 her group moved to the Department of Medical and Molecular Genetics at King’s College London.
She joined the Francis Crick Institute on a secondment in 2024.